Published in Psychopharmacology (Berl) on November 01, 1998
Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. Br J Clin Pharmacol (2003) 0.87
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. Int J Neuropsychopharmacol (2015) 0.75
Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study. Br J Clin Pharmacol (2008) 0.75
Effect of oral linezolid on the pressor response to intravenous tyramine. Br J Clin Pharmacol (2004) 0.75
Improved statistical analysis of moclobemide dose effects on panic disorder treatment. Eur Arch Psychiatry Clin Neurosci (2009) 0.75
Patient satisfaction: a review of issues and concepts. Soc Sci Med (1997) 8.69
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Response rate in patient satisfaction research: an analysis of 210 published studies. Int J Qual Health Care (1998) 3.78
HIV infection and South-West general practitioners. J R Soc Health (1989) 3.49
Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob Agents Chemother (2002) 3.40
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet (1997) 2.77
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab Dispos (2003) 2.32
In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents. Antimicrob Agents Chemother (1983) 2.31
Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology (2008) 2.31
Perceptions and reactions of the public to diarrhoea. J R Soc Health (1993) 2.22
Home standards of sterilization of infant feeding bottles and teats. Mon Bull Minist Health Public Health Lab Serv (1966) 2.10
Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry (1987) 1.96
Effects of mechanical signaling on plant cell cytosolic calcium. Proc Natl Acad Sci U S A (1995) 1.63
Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology (2002) 1.60
[Pharmacokinetics of midazolam after i.v. administration (author's transl)]. Arzneimittelforschung (1981) 1.58
Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci (1979) 1.56
Aetiology and incidence of facial fractures in adults. Int J Oral Surg (1983) 1.49
Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV) J Acquir Immune Defic Syndr (1993) 1.48
Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol (1983) 1.46
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Traumatic aneurysms of the internal maxillary artery and their treatment by embolisation: a report of two cases. Br J Oral Maxillofac Surg (1990) 1.39
Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination. Hum Mol Genet (1998) 1.38
Bioavailability from various galenic formulations of flunitrazepam. Arzneimittelforschung (1977) 1.19
Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol (2004) 1.18
Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells. J Immunol (1988) 1.17
[New theoretical values in exploration of the respiratory function of the lung]. Bull Physiopathol Respir (Nancy) (1972) 1.17
Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry (1996) 1.15
Sex-dependent rearrangements resulting in CMT1A and HNPP. Nat Genet (1997) 1.15
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene (2006) 1.11
Induction of IgE synthesis in normal human B cells. Sequential requirements for activation by an alloreactive T cell clone and IgE-potentiating factors. J Exp Med (1986) 1.10
Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol (1999) 1.10
De novo expansion of intermediate alleles in spinocerebellar ataxia 7. Hum Mol Genet (1998) 1.09
Pharmacokinetics of acetaminophen elimination by anephric patients. J Pharmacol Exp Ther (1976) 1.09
Pharmacokinetic and clinical considerations in the choice of a hypnotic. Br J Clin Pharmacol (1983) 1.09
Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child (2008) 1.08
Elevation of a gamma delta T cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (1991) 1.07
Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet (2000) 1.06
The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus. Am J Hum Genet (1996) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Controlled trial of the subjective patient benefits of accompanied walking to the operating theatre. Int J Clin Pract (1998) 1.04
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol (2003) 1.04
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport (1999) 1.04
Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry (1988) 1.02
Bioavailability under variable renal clearance conditions. J Pharm Sci (1979) 1.01
[Relationship between clinical effects and pharmacokinetics of midazolam on i.m. and i.v. application to volunteers/1st comm.: Clinical aspects (author's transl)]. Arzneimittelforschung (1981) 1.01
Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing. J Pharmacokinet Biopharm (1982) 1.01
Pharmacokinetic profile of fesoterodine. Int J Clin Pharmacol Ther (2008) 1.00
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res (1993) 1.00
Localization of the gene for distal hereditary motor neuronopathy VII (dHMN-VII) to chromosome 2q14. Am J Hum Genet (2001) 0.99
Pharmacokinetic and clinical observations on prolonged administration of flunitrazepam. Eur J Clin Pharmacol (1980) 0.99
Effect of altered disopyramide binding on its pharmacologic response in rabbits. J Pharmacol Exp Ther (1982) 0.98
Enhanced transepithelial transport of peptides by conjugation to cholic acid. Bioconjug Chem (1997) 0.97
Cell-mediated cytotoxicity against skin fibroblasts in atopic dermatitis. J Immunol (1982) 0.97
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol (1979) 0.97
Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study. J Comput Aided Mol Des (1997) 0.97
A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychiatry (2001) 0.96
Clinical genetics of familial progressive supranuclear palsy. Brain (1999) 0.95
Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine (2013) 0.94
Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience (2011) 0.94
Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. Virology (2009) 0.93
Developing performance measures for sedation and analgesia: the approach of the Quality Indicator Project. J Healthc Qual (2001) 0.93
Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states. J Neural Transm Suppl (1989) 0.93
The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine. Curr Med Chem (2009) 0.93
Circulating IgG autoantibodies to IgE in atopic syndromes. J Allergy Clin Immunol (1986) 0.93
Pharmacology of flumazenil. Acta Anaesthesiol Scand Suppl (1995) 0.93
Effect of saturable binding on the pharmacokinetics of drugs: a simulation. J Pharm Pharmacol (1980) 0.93
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br J Psychiatry (1992) 0.91
Genetic complexity and Parkinson's disease. Science (1997) 0.91
Systemic amyloid deposits in familial British dementia. J Biol Chem (2001) 0.91
EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. Eur J Neurol (2001) 0.91
Potentiation of human immunoglobulin E synthesis by plasma immunoglobulin E binding factors from patients with the hyperimmunoglobulin E syndrome. J Clin Invest (1986) 0.90
Invasive group A streptococcal disease in North Queensland (1996 - 2001). Indian J Med Res (2004) 0.90
Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid (2001) 0.90
[Pharmacokinetics of soporific drugs]. ZFA (Stuttgart) (1980) 0.89
Genes and parkinsonism. J Neurol Neurosurg Psychiatry (1997) 0.89
High-affinity interleukin-2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis. Arthritis Rheum (1988) 0.89
Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol (2001) 0.89
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. Clin Neuropharmacol (1996) 0.89
Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat (1997) 0.89
A fluorometric method for direct determination of total salicylate in plasma. Pharm Acta Helv (1972) 0.89
Reducing waiting times associated with an integrated child health service. J R Soc Promot Health (2002) 0.89
Evaluation of the efficacy and tolerance of orally administered midazolam as hypnotic agent compared with oxazepam in the treatment of insomnia of mild to moderate severity. Arzneimittelforschung (1981) 0.89
Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity. Pharm Res (1997) 0.89
A simple method of freezing and storing live lymphocytes. Tissue Antigens (1972) 0.88
Seasonal variations in activity concentrations of 99Tc and 137Cs in the edible meat fraction of crabs and lobsters from the central Irish Sea. J Environ Radioact (2004) 0.88
Parkinson's disease genetics comes of age. BMJ (1999) 0.87
Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines. Anticancer Res (1999) 0.87
Cellular basis of defective cell-mediated lympholysis in atopic dermatitis. J Immunol (1983) 0.87
Influence of food on the pharmacokinetic profile of fesoterodine. Int J Clin Pharmacol Ther (2009) 0.86
Mechanism of action of a new macromolecular antitumor antibiotic, C-1027. J Antibiot (Tokyo) (1990) 0.86
Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies. J Clin Psychopharmacol (1995) 0.86
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. Int Clin Psychopharmacol (1997) 0.86
Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol (2000) 0.85
Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model. Brain Res (1980) 0.85
EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. First of two parts. Eur J Neurol (2001) 0.85
Drug distribution and binding. J Clin Pharmacol (1987) 0.84
The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivative. Int J Clin Pharmacol Biopharm (1977) 0.84
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Braz J Med Biol Res (2011) 0.84
[New normal values for the pulmonary function test with whole body plethysmography]. Dtsch Med Wochenschr (1969) 0.84